Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations.
Yingyun ZhangWei WangXuedong XuYankang LiHui ZhangJianbin LiZhenxiang LiPublished in: Cancer management and research (2021)
MSR improves survival outcomes in patients with advanced-stage, EGFR-mutant, lung adenocarcinoma, with thoracic radiotherapy having the most significant effect on prognosis.